XINROI PHARMACEUTICAL INTERNATIONAL HOLDINGS LIMITED FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 29 FEBRUARY 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged in February at 3,000,000,000 shares with a face value of HK$0.05 per share and a total share capital of HK$150,000,000. In addition, the number of stock options outstanding as of the end of February was 143,200,000 under the Company's stock option plan, which was unchanged during the month. Company Secretary Wu Zhisheng confirmed that all securities issuance has been authorised by the Board and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.

XINROI PHARMACEUTICAL INTERNATIONAL HOLDINGS LIMITED FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT HOLDINGS LIMITED ON 29 FEBRUARY 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged in February at 3,000,000,000 shares with a face value of HK$0.05 per share and a total share capital of HK$150,000,000. In addition, the number of stock options outstanding as of the end of February was 143,200,000 under the Company's stock option plan, which was unchanged during the month. Company Secretary Wu Zhisheng confirmed that all securities issuance has been authorised by the Board and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.